ABOUT US

The RUNX1 Research Program (RRP) is a registered 501(c)(3) charitable organization and the only group worldwide committed to leading advocacy and advancing research for families impacted by RUNX1 familial platelet disorder (RUNX1-FPD).

At RRP, we provide personalized support to patients and their families, connecting them with healthcare professionals and researchers to enhance awareness and understanding of the disorder. Driven by patient insights and needs, our community brings together diverse perspectives to advance pioneering research in cancer prevention.

Our commitment to maximizing the impact of every dollar spent on research is demonstrated through strategic partnerships with esteemed organizations. These collaborations, including our co-funding initiatives with The Mark Foundation for Cancer Research, the EvansMDS initiative (a funding initiative of the Edward P. Evans Foundation), the Leukemia & Lymphoma Society (LLS), and Alex’s Lemonade Stand Foundation (ALSF), amplify our efforts to fund vital research.

Our Partners


Meet The Babiches

Monica and Tim Babich founded RRP in early 2016 after discovering that RUNX1-FPD had been inherited across several generations of their family. Initially, they were the only family they knew dealing with this disorder. Since establishing RRP, they have connected with and profoundly impacted the lives of hundreds of patients and families—many of whom had previously felt isolated in their struggle or had been misdiagnosed for years with other disorders.

Tim Babich
Co-Founder & Director

Monica Babich
Co-Founder & Director

Dr. Katrin Ericson, Executive Director

Dr. Ericson joined RRP as Executive Director in 2018, overseeing the organization’s overall strategy and leading all of RRP’s research programs. She brings a diverse set of experiences that span multiple sectors of the scientific and medical landscape.

Most recently, she was a Medical Director at Amgen working in the Hematology/ Oncology therapeutic area. She was part of both drug development and commercialization processes, working on assets in early stage clinical trials and in life-cycle management.

Prior to Amgen, Dr. Ericson was at the Prostate Cancer Foundation, where she managed their multi-million dollar scientific awards program.

Before joining PCF, Dr. Ericson completed her Ph.D. training at UCLA under the mentorship of Dr. Hanna Mikkola. Her thesis work focused on the hemogenic endothelium during embryonic development. Her research evaluated both the cellular and molecular factors that contribute to hematopoietic stem cell generation and expansion. Interestingly, she used mouse models that tracked the expression of the *RUNX1* gene to identify the hemogenic endothelium.

RRP Team Bios

Dr. Amanda Eggen

Catherine Pelton

Lydia Harper

Mary Silverstein

Mary Silverstein